PUBLISHER: The Business Research Company | PRODUCT CODE: 1942519
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942519
The cardiac pacemaker is defined by small electronic devices that generate electrical impulses to regulate heartbeats and treat conditions like arrhythmias. These devices play a crucial role in preventing the heart from beating too fast or too slow.
The primary categories of cardiac pacemakers consist of implantable and external variants. Implantable cardiac pacemakers, installed through surgery, are electronic devices generating electrical impulses within the chest to maintain a regular heart rate. Different technologies in cardiac pacemakers encompass biventricular, single-chambered, and dual-chambered systems. These devices find applications in treating various conditions such as arrhythmias, heart blockage, atrial fibrillation, long QT syndrome, and congestive cardiac failure. Cardiac pacemakers serve end-users including clinics, hospitals, ambulatory surgical centers, and cardiac care centers. The market continues to evolve with ongoing advancements in technology and surgical procedures, contributing to improved patient care and outcomes.
Tariffs are impacting the cardiac pacemakers market by increasing costs of imported electronic components, batteries, microprocessors, and biocompatible materials used in implantable and external pacemakers. Cardiac care centers in North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces manufacturing cost pressures. These tariffs are raising device prices and extending replacement cycles. However, they are also driving regional component sourcing, localized assembly, and innovation in cost-efficient pacemaker technologies.
The cardiac pacemakers market research report is one of a series of new reports from The Business Research Company that provides cardiac pacemakers market statistics, including cardiac pacemakers industry global market size, regional shares, competitors with a cardiac pacemakers market share, detailed cardiac pacemakers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac pacemakers industry. This cardiac pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac pacemakers market size has grown strongly in recent years. It will grow from $4.95 billion in 2025 to $5.3 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing prevalence of cardiac arrhythmias, expansion of cardiac care infrastructure, rising adoption of implantable cardiac devices, improvements in pacemaker technology, growing aging population.
The cardiac pacemakers market size is expected to see strong growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of smart pacemakers, expansion of ambulatory cardiac procedures, growing focus on personalized cardiac therapy, increasing investments in cardiac digital health. Major trends in the forecast period include increasing adoption of leadless pacemakers, rising use of remote cardiac monitoring systems, growing preference for dual and biventricular devices, expansion of minimally invasive implantation techniques, enhanced focus on device longevity and safety.
The surge in cardiovascular diseases is a significant driver for the cardiac pacemaker market. Cardiovascular diseases encompass a range of disorders affecting the heart or blood vessels, including arrhythmias, aorta disease, congenital heart disease, and heart attacks. To address the growing global health concern, cardiac pacemakers, which generate electric activity, are employed in treating patients with cardiovascular diseases. In September 2023, the World Health Organization reported that annually, 41 million deaths, accounting for 74% of non-communicable diseases, were attributed to cardiovascular diseases, highlighting the pressing need for advancements in cardiac care. Consequently, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the cardiac pacemaker market.
Major companies in the cardiac pacemaker market are innovating products such as i2i communication technology, which facilitates real-time communication between two devices. This i2i (infrastructure-to-infrastructure) communication technology allows seamless data exchange between different infrastructure systems, enhancing automation and operational efficiency. For example, in November 2023, Abbott Laboratories, a US-based medical device company, launched the AVEIR DR System to treat patients with abnormal or slow heart rhythms. This cutting-edge dual-chamber leadless pacemaker system provides synchronized pacing for both the right atrium and ventricle, ensuring a proper heart rhythm. It is implanted using a minimally invasive procedure, which decreases recovery time and complications. The advanced implant-to-implant technology enables real-time communication between the devices, coordinating effective pacing. This innovation marks a significant advancement in heart health management.
In November 2024, Merit Medical Systems acquired Cook Medical's lead-management portfolio for approximately USD 210 million to strengthen its electrophysiology and cardiac rhythm-management business. The acquisition allows Merit to integrate Cook's comprehensive devices and accessories for pacemaker and ICD lead management, including removal and replacement procedures. Cook Medical's established technologies enhance Merit's capabilities in cardiac device management, supporting procedural efficiency and patient safety. This strategic move reflects a broader trend in the cardiac medical devices market toward portfolio expansion through targeted acquisitions of complementary technologies to address growing demand in electrophysiology and rhythm-management solutions.
Major companies operating in the cardiac pacemakers market are Medtronic plc, Abbott Inc, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co. Ltd, MicroPort Scientific Corporation, LivaNova PLC, Zoll Medical Corporation, Oscor Inc, Osypka Medical GmbH, Cardionovum GmbH, Shree Pacetronix Limited, Medico SpA, CCC Medical Devices, Galix Biomedical Instrumentation, Vimecon GmbH, Mediana Co. Ltd, Cardioline SpA, Pacetronix India Pvt Ltd, Beijing Universal Pacing Technology Co. Ltd
North America was the largest region in the cardiac pacemakers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac pacemakers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiac pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cardiac pacemaker market consists of sales of single chamber, dual chamber and Biventricular pacemakers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Pacemakers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiac pacemakers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiac pacemakers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac pacemakers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.